Any tumour growing within (dermal), on (epidermal) or even under the skin (subdermal) should be considered a skin tumour. Some skin tumours are benign (i.e., slow-growing, completely curable with complete resection and dont spread) while others are malignant (faster growing, invasive, sometimes incurable, and may spread to other organs). In order to classify what type of tumour you are dealing with, you will need to make a fine needle aspirate or take a biopsy A biopsy can either be incisional or excisional. Whichever course is taken, a microscopic diagnosis must always, always be obtained.
No two tumours of the same kind look the same, but very different cancers can appear similar When tumours are inflamed or infected, the underlying pathology can be masked. This information is very important. If its a cytological or incisional, this information can help guide you as the best approach to cure not only the obvious lump but also manage the precancerous lesions that surround the obvious tumour. Not all skin tumours are best removed surgically! Only very small (1 2 cm on the body or neck, and <1 cm elsewhere) should be removed by excision.
Many clients and vets try to economise by removing small lumps instead of taking the extra step this can drastically alter prognosis, by spreading tumour cells.
Although theoretically any tumour can occur in the skin, we classically think of just a few types when we say skin cancer squamous cell carcinomas (SCC), melanomas, haemangiosarcomas (HSA) and mast cell tumours (MCT).
Actinic keratosis (AK), also known as solar keratosis or senile keratosis, is a very common lesion occurring in susceptible humans as a result of prolonged and repeated solar exposures. The action of ultraviolet radiant energy, principally UVB, results in damage to the keratinocytes and produces single or multiple, discrete, dry, rough, adherent scaly lesions. These premalignant lesions may, in time, progress to squamous cell carcinomas.
This is very important as a warning sign and should be the first thing you teach clients about. A couple of veterinary-specific manifestations of AK are the comedones or blackheads seen on cats noses (fig 1) and dogs ventra. These lesions can be managed with protection, (fig 2) imiquimod or Photodynamic Therapy (PDT). More on these modalities later.
Squamous Cell Carcinomas
Squamous Cell Carcinomas are the classical skin tumours, caused primarily by long-term to exposure to UV-B radiation. The animals most afflicted white or part-white cats and dogs. Bull Terriers, Staffies, Pit Bulls, Bulldogs and Jack Russells are amongst the dog breeds most often affected. These ex-British breeds enjoy our long, glorious South African summer sun, and tan day after day.
UV-B radiation damages DNA and this damage is cumulative and only partially repairable or reversible. Squamous cell carcinomas can look like nothing more than non-healing crusts, pimples or scabs, or they can form large, raised, ulcerating plaques.
It is important to treat according to the stage presented:
T0 = no tumour
T in situ = Pre-invasive carcinoma (scale, crust)
T1 = tumour <2cm diameter, superficial or exophytic
T2 = tumour 2 5 cm diameter, OR with minimal invasion irrespective of size
T3 = tumour > 5cm diameter, or with invasion of subcutis irrespective of size
T4 = invading fascial, muscle, bone or cartilage, regardless of size
Regional lymph nodes:
N0 = no involvement
N1 = lymphnodeinvolvement
M0 = no metastasis
M1 = evidence of metastasis
Ulceration of the primary tumour is associated with a biologically more aggressive lesion and a poorer prognosis. It is not known why ulcerated primaries have a more aggressive biologic nature. It is not likely due to underestimation of the thickness due to the ulcer crater. Ulcerated lesions tend to be thicker and have a nodular growth pattern, but the increased thickness does not account for the poorer prognosis. However, the depth or width of surface ulceration has been significantly correlated with survival. Other histologic prognosticators include the mitotic indices, whirling and the presence or absence of lymphatic or blood vessel invasion are relevant to prognosis.
Tumours in situ look like nothing more than scaly, scabby skin and offer another earlier warning sign, the best opportunity for cure, and are a wake up call. My preference for this is to use immunotherapy with imiquimod cream, or photodynamic therapy for T in situ and T1 tumours.
T2 tumours which are large but NON invasive (T2 large) also respond well to PDT or radiotherapy, but those that are T2 invasive require surgery or aggressive PDT (only to 5mm depth maximum). Once it gets to T2 invasive or T3+, cure rates using any technique drop to below 40% (from >85%) so teach your pet owners about skin cancer and early aggressive intervention from the first vaccination!
T3 and T1-4N/(any) M0/1 must be referred to a specialist for management. I see huge disasters when GPs approach these with surgery. Dogs are disfigured and then referred when they could have kept penises, mobility or faces with a proper approach from the beginning. An integrated approach using multiple modalities and an understanding of tissue tolerances, treatment sequencing and proper patient surveillance are beyond the scope of general practice. Managing such a patient is often possible, but is an 8 20 week process.
More extensive tumours may require additional surgery, chemotherapy or radiation to achieve good results. Their main importance is that they recur because skin of the ventral abdomen, ears or nose have been damaged. (fig 3) Cutting out squamous cell carcinomas can be like the little Dutch boy plugging the hole in the dyke with a finger another often just pops up elsewhere.
Recurrent SCC may require specialist attention to get under control or cure. In any event, thoracic radiographs should be performed. SCC of the feet (pedal SCC) is far more aggressive and spreads to the lungs earlier than other SCC of the skin, so always attend to any non-healing wound or lump of >1 weeks duration by having it checked using histopathology.
Figure 1. White cat with nasal SCC this is the earliest stage the presence of discharge and slight scaling around the nose and eyelids. If treated appropriately at this stage, the prognosis for cure is close to 100%
Figure 2. UV suit UV-resistant suits (obtained from Dr Georgina Crewe), protect the healthy or precancerous skin and are an essential part of post-treatment management
Photodynamic Therapy (PDT) (fig 4) is a technique using the application or injection of photosensitising agents in different concentrations. They accumulate in certain tumours and when subjected to high-fluence (200-300 W/cm2) light of a specific frequency, keyed to the particular molecule being used, the molecules aggregate into unstable complexes that then restabilise by release of various oxygen radicals which cause lipid membrane, protein and DNA damage. Over-treatment causes regional vasoconstriction and side effects, without increase in toxicity; undertreatment achieves little, but aggravates the inflammation. This treatment is effective only in lesions <5mm thick. Treatment is once a monthly, for 1 3 treatments, depending on severity and extent. Pre-cancerous actinic keratosis can also be successfully managed using this technique.
Immunotherapy using Imiquimod (Aldara; 3M), animidazoquinolinamine, is an immune system modulator and possesses both potent antiviral and antitumor activity in animal models and humans. Current theories suggest that imiquimod acts both directly by inducing apoptosis and by inducing secretion of pro-inflammatory cytokines. Imiquimod activates macrophages and other cells via binding to cell surface receptors, such as Toll receptor 7, and thereby induces secretion of pro-inflammatory cytokines such as interferon-a (IFN-a), tumour necrosis factor-a (TNF-a), and interleukin-12 (IL- 12). These cytokines bias towards a Th1-dominant immune response, which in general is associated with inflammation and tissue injury through activated inflammatory leukocytes and with cytolytic activity through CD8+-lymphocytes (Abbas et al 1996). Imiquimod can also induce apoptosis directly in a Bcl- 2-family-dependent manner by downregulating anti-apoptotic genes such as hurpin and HAX-1.
Treatment is applied to lesions Monday to Friday, once daily, for 6 12 weeks; inflammation caused by the treatment can occasionally be severe and require NSAIDs.
I reserve this for small/early/superficial lesions in cats due to the cost of the cream. Clients must wear gloves to protect themselves. Efficacy is reported as about 75%, with a median survival time of 1189 days, although recurrent lesions do seem to respond to the therapy.
5-Fluorouracil use in animals: this drug is rapidly and fatally neurotoxic in cats even as eye drops. In dogs, the tolerance is also very low and if licked it can trigger fatal mucosal sloughing. Dont use in veterinary practice.
CRYOTHERAPY is outdated, painful, disfiguring and has a lower success rate than other therapies mentioned. Do not use this. Poor technique is a major reason for treatment failure; it requires training and experience and is potentially hazardous to the operator.
RADIATION THERAPY: the use of a linear accelerator to deliver high-voltage (4 20 MeV) electrons or photons for the treatment of surface tumours is called teletherapy. This technique has the potential for extreme harm if improperly performed, and all such cases are specialist cases and must be referred to a person with the relevant training. Theres a reason its an entire field of speciality in itself in the US and Europe. It requires a knowledge of radiation physics, radiation biology and management of radiation side effects that cannot be gleaned from a few lectures.
The role of surgery in managing skin tumours.
Surgery is an important part of management of these conditions. For some tumours e.g. BCC, HA/HSA, MCT, a properly-performed excision can be curative. In others, e.g. SCC, the surrounding skin is often also on an anaplastic march that is unstoppable by surgery alone. Surgery then helps debulk larger masses that would not respond as well to wider-field but lower-intensity therapies e.g. imiquimod, PDT, RT. The timing and planning is critical. Discuss this with a specialist BEFORE radiation or PDT PLEASE! Post-surgical fibrosis decreases the efficacy of other modalities! (fig 5)
Figure 3. SCC ear pinna removal This is the degree of surgery required for more advanced SCC of the pinna, and is to be avoided if possible, by appropriate education of the client at first vaccination of the kitten. This sort of cat may be allowed out at night, but not during the daytime.
Figure 4. PDT Patient undergoing photodynamic therapy at Inanda Vets. Basal Cell Carcinomas
Basal cell tumours are a benign tumour that look very similar to SCC, and are quite common in cats in other parts of the world. In dogs, they typically occur around the head and are not unlike canine cutaneous histiocytoma (hence the need for a tissue diagnosis). They are usually single, raised, ulcerated button-like tumours. Surgery alone is normally curative. They can be diagnosed by cytology or histopathology. BCC and SCC are classed together as the Keratinocytic Skin Cancers.
Figure 5. Multiple raised SCC on the ventrum of a dog; the previous surgeries have contributed to scar tissue formation, which makes radiation less effective, and future surgeries more difficult. The widespread nature of the disease means a novel approach must be taken if control is to be achieved. Patients arriving at this stage are major challenges to cure.
BERGMAN, P. J. 2007. Anticancer vaccines. Vet Clin North Am Small Anim Pract, 37, 1111-9; vi-ii.
BROCKLEY, L. K., COOPER, M. A. & BENNETT, P. F. 2013. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival. N Z Vet J, 61, 25-31.
DANK, G., RASSNICK, K. M., SOKOLOVSKY, Y., GARRETT, L. D., POST, G. S., KITCHELL, B. E., SELLON, R. K., KLEITER, M., NORTHRUP, N. & SEGEV, G. 2012. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Vet Comp Oncol, 9999.
EMANUEL, E. J. & JOFFE, S. 2003. Ethics in Oncology. In: HOLLAND, M. & FREI, E. (eds.) Cancer Medicine 6. 6th ed.: Lippincott.
GILL, V. L., BERGMAN, P. J., BAER, K. E., CRAFT, D. & LEUNG, C. 2008. Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005). Vet Comp Oncol, 6, 55-64.
GROSENBAUGH, D. A., LEARD, A. T., BERGMAN, P. J., KLEIN, M. K., MELEO, K., SUSANECK, S., HESS., P. R., JANKOWSKI, M. H., KURZMAN, I. & WOLCHOK, J. D. 2011. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. American Journal of Veterinary Research, 72, 1631-1638.
KILLICK, D. R., STELL, A. J. & CATCHPOLE, B. 2015. Immunotherapy for canine canceris it time to go back to the future? J Small Anim Pract, 56, 229-41.
MARTIN, P. D. & ARGYLE, D. J. 2013. Advances in the management of skin cancer. Veterinary Dermatology, 24, 173-e38.
MCLEAN, J. L. & LOBETTI, R. G. 2015. Use of the melanoma vaccine in 38 dogs: The South African experience. J S Afr Vet Assoc, 86, 1246.
OTTNOD, J. M., SMEDLEY, R. C., WALSHAW, R., HAUPTMAN, J. G., KIUPEL, M. & OBRADOVICH, J. E. 2013. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol, 11, 219-29.
PETERS-KENNEDY, J., SCOTT, D. W. & MILLER, W. H., JR. 2008. Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream. J Feline Med Surg, 10, 593-9.
Photos: Courtesey Inanda Vet (Dr Anthony Zambeli)
Squamous Cell Carcinoma in Dogs and Cats - Vet360
- Reported stem cell treatment could give hope to Michael Schumacher - Stuff.co.nz - September 18th, 2019
- USC researchers untangle cellular reprogramming to help treat diseases - USC News - September 18th, 2019
- India- Cell Counting Market Size is Estimated to Value $10679.7 Million By 2025: Grand View Research, Inc - MENAFN.COM - September 18th, 2019
- CyTOF Inventors Receive Prestigious Science and Technology Award from the Human Proteome Organization (HUPO) - Yahoo Finance - September 18th, 2019
- Genome-editing shows potential for treating HIV in patient - BioNews - September 18th, 2019
- New technology developed to screen for Huntington's treatments - Drug Target Review - September 18th, 2019
- Device can produce synthetic human embryo-like parts - Washington Times - September 18th, 2019
- Global Advanced Wound Care Markets to 2024: Emerging Technologies such as Crab Shell Bandages, Bacteriophages, Platelets, and Stem Cell Therapies are... - September 18th, 2019
- Growth of the Global Cord Blood Stem Cell Market Driven by Improvements in Product Design - Business Broker - September 18th, 2019
- Couple give embryos, 'hope' to UM in fight against rare disease - The Detroit News - September 18th, 2019
- Induced Pluripotent Stem Cell Market Estimated to be Driven by Innovation and Industrialization - Wolf Mirror - September 18th, 2019
- Research: By exploiting a feature of the immune system, researchers open the door for stem cell transplants to repair the brain - Tdnews - September 18th, 2019
- Study Of Stem Cell Cartilage Regeneration Market And Also Elements For Its Future Growth 2026 - Coherent Magazine - September 18th, 2019
- Attorney General trying to intimidate witness testifying about live fetal hearts: lawyers - Lifesite - September 18th, 2019
- Global Stem Cell Therapy Market Expects an Extensive Growth in ROI of USD 4759.27 Million By 2024 - News Hours Today - September 18th, 2019
- Demand for Stem Cell-Derived Cells Market Driven by Shifting Consumer Perceptions and Growing Awareness - My Health Reporter - September 18th, 2019
- Major Players of Serum-Free Media Market By Type: protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media -... - September 18th, 2019
- Cancer Stem Cell Market Insights on Upcoming Trends 2025 - Spaceflight News - September 18th, 2019
- X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and Development - Business Wire - September 18th, 2019
- Pathogenic Escherichia coli | Nature Reviews Microbiology - May 27th, 2019
- Pathways to Stem Cell Science | Pluripotent Stem Cell ... - May 14th, 2019
- What are the unique properties of stem cells - answers.com - May 2nd, 2019
- Pathways to Stem Cell Science | Intro to Stem Cell Systems - April 6th, 2019
- Perception of Depth by Michael Kalloniatis and Charles Luu ... - March 18th, 2019
- Why does my DAB signal disappear so quickly? - March 10th, 2019
- Atmospheric & Environmental Chemistry | Aerodyne Research ... - March 6th, 2019
- Anyone have objective data on the effectiveness of the ... - February 9th, 2019
- Learn Zone - VetCompass - Royal Veterinary College, RVC - February 9th, 2019
- Retinitis Pigmentosa - The Foundation Fighting Blindness - February 6th, 2019
- Everything You Need To Know About The Bionic Eye - The ... - February 6th, 2019
- Menstrual cycle - Wikipedia - February 2nd, 2019
- Barnesville.com - January 28th, 2019
- Cigarette lighter using rechargeable AA batteries ... - January 28th, 2019
- YNS Cosmeceutical Skincare - Top Skin Care Products - January 28th, 2019
- Best Bourbon. Rankings of Best Bourbon - Bourbon Reviews - January 28th, 2019
- Practical Statistics for Medical Research (Chapman & Hall ... - December 21st, 2018
- A Rare Side Effects of Stem Cell Therapy: A Case Study - October 11th, 2018
- Interstellar Trade - Atomic Rockets - October 11th, 2018
- Stem Cell Research | The Center for Bioethics & Human Dignity - September 29th, 2018
- Stem Cell Research | NWABR.ORG - September 29th, 2018
- Stem Cell Research Program Grants portal.ct.gov | Stem ... - September 29th, 2018
- What is Stem Cell Research? (with pictures) - wisegeek.com - August 23rd, 2018
- Pros And Cons Of Stem Cell Research - Popular Issues - June 21st, 2018
- Stem Cell Basics II. | stemcells.nih.gov - June 21st, 2018
- CReM Honored for Sharing Stem Cell Lines - BU Today - September 8th, 2017
- Researchers Turn Skin Cells into Motor Neurons Without Using Stem Cells - Futurism - September 8th, 2017
- Transformative technology: Encapsulated human cells to ... - Medical Xpress - September 8th, 2017
- Stem Cell Factor Tied to Reduced Risk of Cardiac Events, Death - Anti Aging News - September 8th, 2017
- Italian scientists welcome surprise 400 million boost for basic research - Science Magazine - September 8th, 2017
- This New, Cutting-Edge Treatment Could Be the End of Baldness - Reader's Digest - September 6th, 2017
- Zika Virus Could One Day Help Treat A Deadly Form Of Brain Cancer - HuffPost - September 6th, 2017
- Curved substrates restrict spreading and induce differentiation of stem cells - Phys.Org - September 6th, 2017
- UCSD Researchers Win $18 Million Grant to Fund B-Cell Cancers Clinical Trial - Times of San Diego - September 5th, 2017
- UNMC research traces glaucoma, often associated with aging, to earliest days of development - Omaha World-Herald - September 3rd, 2017
- Landmark stem cell paper questioned - BioEdge - September 3rd, 2017
- Dr Con Man: the rise and fall of a celebrity scientist who fooled almost everyone - The Guardian - September 1st, 2017
- FDA Should Tread Carefully with Stem Cell Regulation - Pain News Network - September 1st, 2017
- Brainstorm Health: Hospitals and Harvey, VR Dementia Research, Stem Cell 'Bad Actors' - Fortune - August 30th, 2017
- Bone Marrow Protein May Be Target for Improving Stem Cell ... - Penn: Office of University Communications - August 30th, 2017
- RNA discoveries could improve stem cell research - Phys.Org - August 30th, 2017
- Stem cell research could double avo production - Fruitnet - August 25th, 2017
- Stem Cell Treatment for Children With Spina Bifida Helps Dogs First ... - UC Davis - August 25th, 2017
- Human stem cell defenses activated by irradiation, study finds - Phys.Org - August 25th, 2017
- For Immune System Stem Cell Studies, Mice Aren't Enough - Science 2.0 - August 23rd, 2017
- North Carolina Advances in Stem Cell Therapy for Lung Diseases Could Lead to Clinical Trial Soon - Lung Disease News - August 23rd, 2017
- Vitamin C Regulates Stem Cell Function - Technology Networks - August 23rd, 2017
- Belize Biochemist's Groundbreaking Stem Cell Research - Channel 7 Daily News - August 22nd, 2017
- Scientists discover vitamin C regulates stem cell function, curbs leukemia development - Medical Xpress - August 22nd, 2017
- Stem cell technique could reverse a major type of infertility - New Scientist - August 17th, 2017
- UCLA scientists identify a new way to activate stem cells to make hair grow - UCLA Newsroom - August 17th, 2017
- Deval Patrick's 10-year, $1B life sciences plan bears fruit in Mass. - The Recorder - August 17th, 2017
- Stem cell agency eyes survival options - Capitol Weekly - August 17th, 2017
- Blood cancer: High doses of vitamin C could encourage stem cells to die - Express.co.uk - August 17th, 2017
- High school student gets an early start in stem cell research at USC - USC News - August 2nd, 2017
- Hypothalamic Stem Cells Could Provide New Insights Into Aging - Futurism - August 1st, 2017
- Stem cell brain implants could 'slow ageing and extend life', study shows - The Guardian - July 30th, 2017
- Q&A: Regulating Stem Cell Therapy - MedPage Today - July 30th, 2017
- UCI stem cell therapy attacks cancer by targeting unique tissue stiffness - UCI News - July 30th, 2017
- Cancer stem cells target of new grant to UCSD scientists - The San Diego Union-Tribune - July 30th, 2017
- UCI researchers use stem cells as cancer-seeking missiles - 89.3 KPCC - July 30th, 2017